Pharma News, 2024

The FDA has approved the first treatment for schizophrenia that targets cholinergic receptors rather than dopamine receptors.

Some counterfeits contain bacteria and have high impurity levels or different chemical structures to FDA-approved medicines.

Boehringer Ingelheim has opened a €60m ($66.8m) research building in Vienna, Austria, as the company looks to double down in the oncology therapeutics space. The building is named after Ange...

U.S. Food and Drug Administration approved osimertinib (Tagrisso) for adults with locally advanced, unresectable stage III non-small cell lung cancer (NSCLC) who have not experienced d...

A new study details how a nasal spray formulated by investigators from Brigham and Women's Hospital may work to protect against viral and bacterial respiratory infections. Based on their preclinic...

Researchers find that the antidepressant vortioxetine may offer new hope for glioblastoma patients by crossing the blood-brain barrier and significantly reducing tumor size in preclinical models.

The US Food and Drug Administration (FDA) has granted fast-track designation to narmafotinib, Amplia Therapeutics’ lead drug for the treatment of advanced pancreatic cancer. In the future, n...

A new gene therapy ATSN-101 has restored vision in patients with Leber congenital amaurosis type I (LCA1), a rare genetic condition causing blindness. In a small trial, those receiving the hig...

GSK PLC on Friday announced positive headline results of the Matinee phase III clinical trial evaluating Nucala.

The US Food and Drug Administration (FDA) has approved Amneal Pharmaceuticals and Shilpa Medicare’s oncology product BORUZU for subcutaneous administration. BORUZU, the first ready-to-use ve...

Pharma giant Eli Lilly is teaming up with Haya Therapeutics in a $1bn deal to find multiple regulatory-genome-derived RNA-based drug targets, as it eyes up new targets in obesity. Haya could secure up...

The FDA has granted an orphan drug designation (ODD) to the investigational agent certepetide (formerly LSTA1) for the treatment of cholangiocarcinoma, according to an announcement fro...